Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out how to Arrange a Fair Settlement with the Assistance of a Fender bender Legal counselor - 2Knesset sets special panel to fast-track Karhi’s communications reform
- 3Top Smoothie Flavor: What's Your Mix?
- 4Elvis Presley's Infamous Pantera Shooting
- 5How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
- Israel strikes Beirut amid rocket fire from Hezbollah and Iran
- Tech for Learning: Online Courses and Instructive Apparatuses
- The Electric Toyota Hilux Is Finally here, But It's Not Cheap
- Manual for 6 Hot Brilliant Beds
- Financial plan Cordial Home Redesigns That Add Worth
- Canada Awards C$1.5 Billion Defense Contracts to L3Harris, Airbus
- Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- 3 moms, 3 countries, 1 very familiar problem: Why child care costs still don't add up for families
- Manual for Savvy Home Lighting Framework: Lights up Your Space
